Company Search:
Advanced Search
Sponsored Links
Acrux Ltd Company Snapshot
Acrux Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acrux Ltd with three other companies in this sector in AUSTRALIA : Adalta Ltd (2020 sales of 3.85 million Australian Dollars [US$2.98 million] ), MGC Pharmaceuticals Ltd (2.09 million Australian Dollars [US$1.62 million] of which 100% was Supply of medicinal cannabis products), and Pharmaust Limited (4.12 million Australian Dollars [US$3.19 million] ).

Sales Analysis. During the year ended June of 2020, sales at Acrux Ltd were A$3.95 million (US$3.06 million). This is a sharp decrease of 25.4% versus 2019, when the company's sales were A$5.29 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acrux Ltd
  Stock Performance Chart for Acrux Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): .21
(Figures in Australian Dollars)
1 Week 31.3%   13 Weeks 13.5%  
4 Weeks 10.5%   52 Weeks 10.5%  
Acrux Ltd Key Data:
  Ticker: ACR Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 3,945,000
(Year Ending Jan 2021).
Employees: 36
  Currency: Australian Dollars Market Cap: 35,402,538
  Fiscal Yr Ends: June Shares Outstanding: 168,583,515
  Share Type: Ordinary Closely Held Shares: 27,148,172
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.